Discover Lingo's top-performing Instagram ads. Analyze creatives, messaging, and campaign performance.
Get unlimited access to analyze competitor ads, save creatives, and discover winning strategies.
See all ads on AdLibrary →Lingo is Abbott's DTC CGM brand for wellness consumers, launched in the US in September 2024. Built on Abbott's FreeStyle Libre platform, the Lingo biosensor is worn on the upper arm and pairs with a mobile app to provide real-time glucose insights for non-diabetic users interested in nutrition optimization, weight management, and metabolic health. FDA-cleared in June 2024.
